OverviewSuggest Edit

Ekso Bionics is committed to applying the latest technology and engineering to help people rethink current physical limitations and achieve the remarkable. Originally Berkeley Bionics, Ekso Bionics was founded in Berkeley, California in 2005. Since inception Ekso Bionics has forged partnerships with world-class institutions like UC Berkeley, received research grants from the Department of Defense and licensed technology to the Lockheed Martin Corporation. Today Ekso Bionics continues to pioneer the field of exoskeletons, designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human mobility and capability.
TypePublic
Founded2005
HQRichmond, US
Websiteeksobionics.com
Employee Ratings4.1

Latest Updates

Employees (est.) (Dec 2018)77(-13%)
Job Openings1
Revenue (FY, 2018)$11.3 M(+55%)
Share Price (Nov 2019)$0.6

Key People/Management at Ekso Bionics

Jack Peurach

Jack Peurach

President and Chief Executive Officer
Max Scheder-Bieschin

Max Scheder-Bieschin

CFO
Russ Angold

Russ Angold

CTO
Show more

Ekso Bionics Office Locations

Ekso Bionics has an office in Richmond
Richmond, US (HQ)
Richmond, CA, USA
Show all (1)

Ekso Bionics Financials and Metrics

Ekso Bionics Revenue

Ekso Bionics's revenue was reported to be $11.33 m in FY, 2018
USD

Revenue (Q3, 2019)

3.3m

Gross profit (Q3, 2019)

1.8m

Gross profit margin (Q3, 2019), %

52.7%

Net income (Q3, 2019)

206.0k

EBIT (Q3, 2019)

(3.8m)

Market capitalization (15-Nov-2019)

41.6m

Closing stock price (15-Nov-2019)

0.6

Cash (30-Sep-2019)

8.1m

EV

34.5m
Ekso Bionics's current market capitalization is $41.6 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

5.3m8.7m14.2m7.4m11.3m

Cost of goods sold

3.8m7.5m11.3m5.3m7.0m

Gross profit

1.6m1.2m2.9m2.1m4.3m

Gross profit Margin, %

29%14%21%28%38%
Quarterly
USDQ2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Revenue

1.1m1.2m1.6m1.7m2.1m2.9m8.5m1.6m1.6m1.4m1.9m1.6m2.5m3.0m2.6m3.6m3.3m3.3m

Cost of goods sold

582.2k1.2m1.1m1.3m1.6m2.4m7.0m1.3m1.2m1.1m1.5m1.1m1.8m2.0m1.5m2.0m1.7m1.6m

Gross profit

479.5k45.6k479.8k403.0k502.0k468.0k1.5m203.0k403.0k352.0k396.0k544.0k767.0k967.0k1.1m1.6m1.6m1.8m

Gross profit Margin, %

45%4%30%24%24%16%18%13%25%25%21%34%30%33%42%44%48%53%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

29.2k25.2m19.6m16.8m27.8m7.7m

Accounts Receivable

1.5m2.1m2.8m3.7m

Prepaid Expenses

388.0k436.0k1.3m281.0k

Inventories

622.0k1.1m1.6m3.0m3.4m
Quarterly
USDY, 2019

EV/EBIT

-9.1 x

EV/CFO

-2.4 x

Debt/Equity

0.2 x

Financial Leverage

3.2 x
Show all financial metrics

Ekso Bionics Online and Social Media Presence

Embed Graph

Ekso Bionics News and Updates

Ekso Bionics introduces EksoNR exoskeleton for neurorehab

Ekso Bionics, the Richmond, Calif.-based developer of medical and industrial exoskeletons, today unveiled EksoNR, the next-generation version of its EksoGT. The EksoNR is designed to help patients who are recovering from stroke or other conditions learn to walk again with a more natural gait. The Ek…

Ekso Bionics Announces Closing of $10 Million Public Offering

RICHMOND, Calif., May 24, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company,” “Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, announced today the closing of its previously announced underwritten public offering…

Ekso Bionics Reports Fourth Quarter and Year End 2018 Results

RICHMOND, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and twelve months ended December 31, 2018.

Medical Exoskeletons Market Comprehensive Study Explores Huge Growth in Future | Cyberdyne, Ekso Bionics, Rewalk Robotics, Bionik Laboratories, Rex Bionics

Stay up-to-date with Medical Exoskeletons market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. Posted via Industry Today. Follow us on Twitter @IndustryToday

Ekso Bionics Announces $100 Million Joint Venture to Develop the Exoskeleton Market in Asia

- Joint Venture is expected to bring therapy to 12 million stroke patients in China alone -

Hybrid Assistive Limb Market to Witness Huge Growth by 2023 | Leading Key Players: AlterG, Cyberdyne, Ekso Bionics, Focal Meditech, Hocoma

A new research study from HTF MI with title Global Hybrid Assistive Limb Market Insights, Forecast to 2025 provides an in-depth assessment of the Hybrid Assistive Limb including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles …
Show more

Ekso Bionics Frequently Asked Questions

  • When was Ekso Bionics founded?

    Ekso Bionics was founded in 2005.

  • Who are Ekso Bionics key executives?

    Ekso Bionics's key executives are Jack Peurach, Max Scheder-Bieschin and Russ Angold.

  • How many employees does Ekso Bionics have?

    Ekso Bionics has 77 employees.

  • What is Ekso Bionics revenue?

    Latest Ekso Bionics annual revenue is $11.3 m.

  • What is Ekso Bionics revenue per employee?

    Latest Ekso Bionics revenue per employee is $147.2 k.

  • Who are Ekso Bionics competitors?

    Competitors of Ekso Bionics include TransEnterix, Central Research Laboratory and Ossur.

  • Where is Ekso Bionics headquarters?

    Ekso Bionics headquarters is located at Richmond, CA, USA, Richmond.

  • Where are Ekso Bionics offices?

    Ekso Bionics has an office in Richmond.

  • How many offices does Ekso Bionics have?

    Ekso Bionics has 1 office.